# ENHERTU
> **BLA761139** · Biologics License Application · Sponsor: DAIICHI SANKYO · Approved 2019-12-20
## Drug
- **FDA Application Number:** BLA761139
- **Application type:** Biologics License Application
- **Brand name:** ENHERTU
- **Generic name:** FAM-TRASTUZUMAB DERUXTECAN-NXKI
- **Active ingredients:** FAM-TRASTUZUMAB DERUXTECAN-NXKI
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** DAIICHI SANKYO
- **Manufacturer:** Daiichi Sankyo Inc.
- **First approval:** 2019-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761139)
---
*AI Analytics · CC0 1.0*